Advertisement

Reactions Weekly

, Volume 1747, Issue 1, pp 115–115 | Cite as

Docetaxel/paclitaxel/pertuzumab/trastuzumab

Various toxicities: 3 case reports
Case report
  • 21 Downloads

Reference

  1. Esin E, et al. Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Cancer Chemotherapy and Pharmacology 83: 131-143, No. 1, Jan 2019. Available from: URL: http://doi.org/10.1007/s00280-018-3712-7 - Turkey

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations